CoverageForm 410-K10-Q8-K13D13G13F

DD · Dupont De Nemours, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · DD

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$1.68B-$3.07B$3.26B$3.07B-$3.19B$3.17B$2.93B-
Cost of Revenue$1.08B-$1.88B$2.04B$1.92B-$2.00B$2.00B$1.92B-
Gross Profit$602.00M-$1.20B$1.22B$1.15B-$1.19B$1.18B$1.01B-
R&D$47.00M-$140.00M$142.00M$137.00M-$134.00M$134.00M$125.00M-
SG&A$255.00M-$387.00M$405.00M$369.00M-$387.00M$418.00M$384.00M-
Total Operating Expenses----------
D&A$155.00M-$267.00M$296.00M$293.00M---$291.00M-
Operating Income$181.00M-$327.00M$306.00M($429.00M)-$586.00M$296.00M$267.00M-
Interest Expense----------
Income Tax$31.00M-$19.00M$68.00M$119.00M-$106.00M$120.00M$84.00M-
Net Income$161.00M-($123.00M)$59.00M($589.00M)-$454.00M$178.00M$189.00M-
EPS - Basic$0.39-($0.29)$0.06($0.59)-$0.46$0.18$0.19-
EPS - Diluted$0.39-($0.29)$0.06($0.59)-$0.45$0.18$0.19-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$710.00M$715.00M$1.96B$1.84B$1.76B$1.85B$1.65B$1.50B$1.93B$2.39B
Accounts Receivable$1.70B$910.00M$2.37B$2.54B$2.29B$1.53B$2.36B$2.31B$2.37B$1.51B
Inventory$1.21B$1.17B$1.84B$2.29B$2.24B$2.13B$2.24B$2.16B$2.17B$2.15B
Accounts Payable$882.00M$995.00M$1.66B$1.70B$1.66B$1.72B$1.70B$1.66B$1.62B$1.68B
Current Assets$5.64B$5.58B$10.02B$6.85B$6.46B$6.36B$6.44B$6.16B$7.07B$7.51B
Total Assets$21.45B$21.57B$38.04B$36.56B$35.98B$36.64B$37.46B$36.55B$37.72B$38.55B
Current Liabilities$2.10B$2.31B$5.00B$4.85B$4.63B$4.80B$2.83B$2.79B$3.03B$3.10B
Long-term Debt------$7.17B$7.17B$7.86B$7.86B
Total Liabilities$7.21B$7.47B$14.70B$13.04B$12.71B$12.84B$12.80B$12.79B$13.71B$13.83B
Stockholders' Equity$14.04B$13.92B$22.89B$23.06B$22.83B$23.35B$24.21B$23.34B$23.58B$24.28B
Retained Earnings($24.20B)($24.28B)($23.73B)($23.61B)($23.66B)($23.08B)($22.96B)($23.41B)($23.52B)($22.87B)

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow$232.00M---$382.00M---$493.00M-
Investing Cash Flow($120.00M)---($202.00M)---($202.00M)-
Financing Cash Flow($189.00M)---($206.00M)---($691.00M)-
CapEx$102.00M---$249.00M---$207.00M-
Free Cash Flow$130.00M---$133.00M---$286.00M-

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin35.8%-38.9%37.3%37.4%-37.4%37.1%34.6%-
Operating margin10.8%-10.6%9.4%-14.0%-18.4%9.3%9.1%-
EBITDA margin20.0%-19.3%18.5%-4.4%---19.0%-
Net margin9.6%--4.0%1.8%-19.2%-14.2%5.6%6.4%-
Free cash flow margin7.7%---4.3%---9.8%-
FCF / Net income0.81----0.23---1.51-
R&D / Revenue2.8%-4.6%4.4%4.5%-4.2%4.2%4.3%-
SG&A / Revenue15.2%-12.6%12.4%12.0%-12.1%13.2%13.1%-
Effective tax rate16.1%--53.5%--18.9%40.3%30.8%-
Return on assets0.8%--0.3%0.2%-1.6%-1.2%0.5%0.5%-
Return on equity1.1%--0.5%0.3%-2.6%-1.9%0.8%0.8%-
Return on invested capital------1.5%0.6%0.6%-
Liquidity
Current ratio2.682.422.001.411.401.332.282.212.332.43
Quick ratio2.111.911.630.940.910.881.491.441.611.73
Cash ratio0.340.310.390.380.380.390.580.540.640.77
Leverage
Debt / Equity------0.300.310.330.32
Debt / Assets------0.190.200.210.20
Debt / EBITDA--------14.09-
Interest coverage----------
Equity multiplier1.531.551.661.591.581.571.551.571.601.59
Liabilities / Assets0.340.350.390.360.350.350.340.350.360.36
Efficiency
Asset turnover0.08-0.080.090.09-0.090.090.08-
Inventory turnover0.89-1.020.890.86-0.890.920.88-
Days sales outstanding369d-282d284d273d-270d266d295d-
Days inventory outstanding409d-358d410d426d-409d396d414d-
Days payable outstanding298d-323d304d315d-311d303d309d-
Cash conversion cycle480d-317d391d384d-368d359d399d-
Valuation
P / E117.4x--489.9x--82.5x191.6x170.4x-
P / B1.3x-0.6x0.5x0.6x-0.6x0.6x0.6x-
P / S11.2x-4.5x3.7x4.3x-4.9x4.5x4.6x-
EV / EBITDA54.2x-19.8x17.0x----35.0x-
Growth
Revenue growth (YoY)-45.2%--3.8%2.7%4.6%-4.4%2.5%-2.9%-
Revenue CAGR (3y)-17.7%--2.5%-0.7%-2.2%--4.2%-1.2%-7.2%-
Revenue CAGR (5y)-14.5%--9.6%-7.6%-10.1%--10.1%-10.3%-31.7%-
Gross profit growth (YoY)-47.5%-0.1%3.5%13.1%-8.2%10.4%-2.1%-
Operating income growth (YoY)---44.2%3.4%--43.6%-16.9%-25.0%-
Net income growth (YoY)----66.9%--42.3%--26.5%-
EPS growth (YoY)----66.7%---35.4%--66.4%-
EPS CAGR (3y)-11.4%---66.4%---15.5%-42.0%-72.3%-
EPS CAGR (5y)-46.5%------2.0%--3.9%-
FCF growth (YoY)-2.3%----53.5%---180.4%-
FCF CAGR (5y)----------
Book value growth (YoY)-38.5%-40.4%-5.4%-1.2%-3.2%-3.8%0.1%-10.7%-11.8%-8.6%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$6.85B total
Diversified Industrials Segment$3.62B · 52.8%
Healthcare And Water Technologies Segment$3.23B · 47.2%

Product / service

$6.85B total
Industrial Technologies$2.00B · 29.2%
Healthcare Technologies$1.76B · 25.7%
Building Technologies$1.61B · 23.6%
Water Technologies$1.48B · 21.5%

Geographic

$7.56B total
US$3.19B · 42.2%
Asia Pacific$1.64B · 21.7%
EMEA$1.47B · 19.4%
CN$708.00M · 9.4%
Latin America$326.00M · 4.3%
CA$227.00M · 3.0%

Peer comparison

Same SIC group: Plastic Materials, Synth Resins & Nonvulcan Elastomers

CompanyRevenue (last FY)Net marginROE
EMN$8.75B5.4%8.0%
AVNT$3.26B2.5%3.4%
TSE$2.97B-18.3%49.7%
DOW$39.97B-6.6%-16.4%
HXL$1.89B7.0%10.6%

Comparing DuPont de Nemours against the 5 most active filers in the same SIC group.

Dividends

$0.77/share trailing 12 months · +16.7% YoY

Ex-datePer share
May 15, 2026$0.2000
Mar 2, 2026$0.2000
Nov 28, 2025$0.2000
Aug 29, 2025$0.1715
May 30, 2025$0.1715
Mar 3, 2025$0.1715
Nov 29, 2024$0.1590
Aug 30, 2024$0.1590
May 31, 2024$0.1590
Feb 28, 2024$0.1590
Nov 29, 2023$0.1506
Jul 28, 2023$0.1506
May 30, 2023$0.1506
Feb 27, 2023$0.1506
Nov 29, 2022$0.1381
Jul 28, 2022$0.1381
May 27, 2022$0.1381
Feb 25, 2022$0.1381
Nov 29, 2021$0.1255
Jul 29, 2021$0.1255
May 27, 2021$0.1255
Feb 26, 2021$0.1255
Nov 27, 2020$0.1255
Jul 30, 2020$0.1255